Nasdaq

Teleflex Incorporated Reports Positive Findings from CLEAR Study on UroLift™ System at EAU Congress 2025

Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...
Seeking Alpha

Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

CLEAR is the first head-to-head randomized controlled trial (RCT) comparing early patient outcomes following treatment with UroLift™ PUL and Rezūm™ WVTT, two minimally invasive treatments for the ...
Nasdaq

Teleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System

WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally ...
Business Insider

Teleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*

Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for Patients with Enlarged ...
Business Insider

Urology Care Specialists Announces Dr. David Schwartzwald's Designation as UroLift® Center of Excellence

BOCA RATON, Fla., Nov. 14, 2018 /PRNewswire-PRWeb/ -- Urology Care Specialists today announced that Dr. David Schwartzwald has been designated as a UroLift® Center of Excellence. The designation ...
Morningstar

UroLift 2 Margin Lift and Elective Procedure Recovery Are Tailwinds for Teleflex in 2022

Over the past decade, Teleflex has transformed from a diverse industrial, commercial, and healthcare company to one focused on single-use medical devices using the dual levers of acquisitions and ...